Guidance

NHS population screening: data requests and research

Role and remit of NHS population screening programmes’ Research, Innovation and Development Advisory Committee

If you have any questions about a screening research application please contact england.screening.research@nhs.net. Meetings dates and application deadlines stated here may no longer be valid.

NHS England (NHS E) are now responsible for the NHS screening programmes functions including the research advisory committees. Their remit have been broadened to include innovation and development to become Research Innovation and Development Advisory Committee (RIDAC)

Purpose

The NHS screening programmes develop and improve as new information becomes available. This information can include:

  • new tests
  • a better understanding of conditions we screen for
  • new ways to engage people in screening decisions

Screening programmes provide a unique opportunity for researchers to explore new tests, treatments and specific hypotheses relating to the screening programmes from a population perspective.

Data collection is integral to all screening programmes and a wealth of data is available to inform policy-making and research.

NHS screening programmes are responsible for ensuring data collected nationally and locally is managed in accordance with data protection and information governance requirements.

It is essential that research, evaluation and audit are feasible, of high quality and protects the safety of patients.

Any research activity must be undertaken in line with current legislation and guidance. Access to data sets comprising identifiable or potentially identifiable screening data or tests requires appropriate legal gateway assurances.

Approval from the NHS Health Research Authority (HRA) Confidentiality Advisory Group (CAG) is needed for some studies using identifiable data without consent. See guidance for CAG applicants for more information.

NHS screening programmes encourage well-designed research that addresses important new questions that will inform, guide and improve the programmes.

Application process

If the application is requesting access to NHSE data it will be reviewed by the Screening Research Office using the

Each of the young person and adult screening programmes has its own RIDAC:

The antenatal and newborn screening programmes are grouped together into one RIDAC:

Terms of reference

See Terms of reference are being adapted at moment by each RIDAC) for guidance on RIDAC aims and objectives, legal issues, ethical issues and membership.

Committee activity and previously approved projects

All projects that have received full approval from a RIDAC are listed on the register of RAC approvals. The RIDAC also publish an annual summary of activity showing the number of applications received and the outcome of decisions.

All personally identifiable or de-personalised data releases for projects will be approved by the RIDAC.

Updates to this page

Published 19 July 2018
Last updated 5 March 2025 show all updates
  1. Removed out of date application form.

  2. Added statement about impact of Public Health England's functions moving to new organisations on 1 October.

  3. Changes to text and links added to RAC approved projects page and data release register.

  4. Added links to Diabetic eye screening: submitting research proposals and Antenatal and newborn screening: submitting research proposals.

  5. Added link to new bowel cancer screening research guidance publication.

  6. First published.

Sign up for emails or print this page